This decision analytical model study quantifies newly eligible treatment candidates for sacubitril/valsartan under the expanded US Food and Drug Administration labeling and uses data from the PARAGON-HF trial to evaluate treatment effects and the number needed to treat to prevent 1 worsening HF event.
This observational study investigates whether myocardial flow reserve and stress myocardial blood flow are associated with left ventricular structure and function derangements, and whether these parameters improve after aortic valve replacement.
This cohort study assesses whether adding premature menopause status to pooled cohort equations improves risk prediction of atherosclerotic cardiovascular disease among women.
This cohort study of individuals with early-onset atrial fibrillation examines the prevalence of disease-associated variants in susceptibility genes for inherited cardiomyopathy and arrhythmia syndromes.
This cross-sectional study determines whether gender differences exist in the reimbursements, charges, and reimbursement per charge from the Centers for Medicare & Medicaid Services.
This Viewpoint discusses the potential value of incidentally observed coronary artery calcification (CAC) in deciding to initiate early prevention, even in the absence of symptoms.
This randomized clinical trial examines the use of differing methods of goal setting and implementation in gamification of individuals at risk for major cardiovascular events.
This post hoc analysis of SPRINT examines whether elevated high-sensitivity cardiac troponin T and N-terminal pro–B-type natriuretic peptide levels can identify individuals with the greatest risk for mortality and heart failure and the largest benefit from intensive systolic blood pressure lowering.
Create a personal account or sign in to: